Basis of Presentation and Summary of Significant Accounting Policies - Schedule of anti-dilutive securities (Details) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
|
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of net loss per share (in shares) | 14,511,763 | 61,598,139 |
| Stock options | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of net loss per share (in shares) | 13,927,935 | 8,481,616 |
| Unvested restricted stock units | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of net loss per share (in shares) | 583,828 | 481,177 |
| Common stock warrants | ||
| Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
| Antidilutive securities excluded from computation of net loss per share (in shares) | 0 | 52,635,346 |